CVM
Price:
$0.8275
Market Cap:
$52.80M
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV...[Read more]
Industry
Biotechnology
IPO Date
1983-12-08
Stock Exchange
AMEX
Ticker
CVM
According to CEL-SCI Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -1.43. This represents a change of -53.67% compared to the average of -3.09 of the last 4 quarters.
The mean historical PE Ratio of CEL-SCI Corporation over the last ten years is -5.23. The current -1.43 PE Ratio has changed 2.64% with respect to the historical average. Over the past ten years (40 quarters), CVM's PE Ratio was at its highest in in the December 2018 quarter at 16.12. The PE Ratio was at its lowest in in the September 2020 quarter at -21.52.
Average
-5.23
Median
-2.76
Minimum
-14.54
Maximum
-0.91
Discovering the peaks and valleys of CEL-SCI Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 396.05%
Maximum Annual PE Ratio = -0.91
Minimum Annual Increase = -71.81%
Minimum Annual PE Ratio = -14.54
Year | PE Ratio | Change |
---|---|---|
2023 | -1.73 | -50.43% |
2022 | -3.48 | -69.45% |
2021 | -11.40 | -21.60% |
2020 | -14.54 | 28.87% |
2019 | -11.29 | 396.05% |
2018 | -2.28 | 149.47% |
2017 | -0.91 | -71.81% |
2016 | -3.24 | 126.59% |
2015 | -1.43 | -27.10% |
2014 | -1.96 | -65.10% |
The current PE Ratio of CEL-SCI Corporation (CVM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.54
5-year avg
-8.49
10-year avg
-5.23
CEL-SCI Corporation’s PE Ratio is greater than CTI BioPharma Corp. (-30.90), less than Agenus Inc. (-0.38), less than Aeterna Zentaris Inc. (-0.10), less than Cyclacel Pharmaceuticals, Inc. (-0.05), greater than BioCryst Pharmaceuticals, Inc. (-10.40),
Company | PE Ratio | Market cap |
---|---|---|
-30.90 | $1.20B | |
-0.38 | $87.58M | |
-0.10 | $17.51M | |
-0.05 | $1.09M | |
-10.40 | $1.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CEL-SCI Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CEL-SCI Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CEL-SCI Corporation's PE Ratio?
How is the PE Ratio calculated for CEL-SCI Corporation (CVM)?
What is the highest PE Ratio for CEL-SCI Corporation (CVM)?
What is the 3-year average PE Ratio for CEL-SCI Corporation (CVM)?
What is the 5-year average PE Ratio for CEL-SCI Corporation (CVM)?
How does the current PE Ratio for CEL-SCI Corporation (CVM) compare to its historical average?